Li et al. reported that ME49-Δompdc inhibits the growth of B16F1 melanoma by eliciting a Th1 immune response, with high levels of IL-12, TNF-α, and IFN-γ and CD8+ T-cell activation in C57BL/6 mice121 (Fig. 3). This evidence concerns the gene CD8A and melanoma.